Literature DB >> 20970500

Fibrillin-3 expression in human development.

Laetitia Sabatier1, Nicolai Miosge, Dirk Hubmacher, Guoqing Lin, Elaine C Davis, Dieter P Reinhardt.   

Abstract

Fibrillin proteins are the major components of extracellular microfibrils found in many connective tissues. Fibrillin-1 and fibrillin-2 are well studied and mutations in these proteins cause a number of fibrillinopathies including Marfan syndrome and congenital contractural arachnodactyly, respectively. Fibrillin-3 was more recently discovered and is much less well characterized. Fibrillin-1 is expressed throughout life, whereas fibrillins-2 and -3 are thought to be primarily present during development. Here, we report detailed fibrillin-3 expression patterns in early human development. A polyclonal antiserum against a C-terminal recombinant half of human fibrillin-3 was produced in rabbit. Anti-fibrillin-3 antibodies were affinity-purified and antibodies cross-reacting with the other fibrillins were removed by absorption resulting in specific anti-fibrillin-3 antibodies. Immunohistochemical analyses with these purified antibodies demonstrate that fibrillin-3 is temporally expressed in numerous tissues relatively evenly from the 6th to the 12th gestational week. Fibrillin-3 was found spatially expressed in perichondrium, perineurium, perimysium, skin, developing bronchi, glomeruli, pancreas, kidney, heart and testis and at the prospective basement membranes in developing epithelia and endothelia. Double immunohistochemical analyses showed that all fibrillins are globally expressed in the same organs, with a number of differences on the tissue level in cartilage, perichondrium and developing bronchi. These results suggest that fibrillin-3, compared to the other fibrillins, fulfills both overlapping and distinct functions in human development.
Copyright © 2010 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20970500      PMCID: PMC4961473          DOI: 10.1016/j.matbio.2010.10.003

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  37 in total

Review 1.  Fibrillin microfibrils.

Authors:  Cay M Kielty; Michael J Sherratt; Andrew Marson; Clair Baldock
Journal:  Adv Protein Chem       Date:  2005

Review 2.  The extracellular matrix in development and morphogenesis: a dynamic view.

Authors:  Tania Rozario; Douglas W DeSimone
Journal:  Dev Biol       Date:  2009-10-23       Impact factor: 3.582

3.  Family-based analysis of candidate genes for polycystic ovary syndrome.

Authors:  Kathryn G Ewens; Douglas R Stewart; Wendy Ankener; Margrit Urbanek; Jan M McAllister; Chen Chen; K Maravet Baig; Stephen C J Parker; Elliot H Margulies; Richard S Legro; Andrea Dunaif; Jerome F Strauss; Richard S Spielman
Journal:  J Clin Endocrinol Metab       Date:  2010-03-03       Impact factor: 5.958

4.  Fibrillins in adult human ovary and polycystic ovary syndrome: is fibrillin-3 affected in PCOS?

Authors:  C Diana Jordan; Sandra D Bohling; Noe L Charbonneau; Lynn Y Sakai
Journal:  J Histochem Cytochem       Date:  2010-10       Impact factor: 2.479

5.  Essential role for fibrillin-2 in zebrafish notochord and vascular morphogenesis.

Authors:  John M Gansner; Erik C Madsen; Robert P Mecham; Jonathan D Gitlin
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

6.  The FBN2 gene: new mutations, locus-specific database (Universal Mutation Database FBN2), and genotype-phenotype correlations.

Authors:  Melissa Yana Frédéric; Christine Monino; Christoph Marschall; Dalil Hamroun; Laurence Faivre; Guillaume Jondeau; Hanns-Georg Klein; Luitgard Neumann; Elodie Gautier; Christine Binquet; Cheryl Maslen; Maurice Godfrey; Prateek Gupta; Dianna Milewicz; Catherine Boileau; Mireille Claustres; Christophe Béroud; Gwenaëlle Collod-Béroud
Journal:  Hum Mutat       Date:  2009-02       Impact factor: 4.878

7.  Differential expression of fibrillin-3 adds to microfibril variety in human and avian, but not rodent, connective tissues.

Authors:  Glen M Corson; Noe L Charbonneau; Douglas R Keene; Lynn Y Sakai
Journal:  Genomics       Date:  2004-03       Impact factor: 5.736

8.  ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome.

Authors:  Nathalie Dagoneau; Catherine Benoist-Lasselin; Céline Huber; Laurence Faivre; André Mégarbané; Abdulrahman Alswaid; Hélène Dollfus; Yves Alembik; Arnold Munnich; Laurence Legeai-Mallet; Valérie Cormier-Daire
Journal:  Am J Hum Genet       Date:  2004-09-13       Impact factor: 11.025

9.  Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils.

Authors:  H Zhang; W Hu; F Ramirez
Journal:  J Cell Biol       Date:  1995-05       Impact factor: 10.539

10.  Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries.

Authors:  Mark J Prodoehl; Nicholas Hatzirodos; Helen F Irving-Rodgers; Zhen Z Zhao; Jodie N Painter; Theresa E Hickey; Mark A Gibson; William E Rainey; Bruce R Carr; Helen D Mason; Robert J Norman; Grant W Montgomery; Raymond J Rodgers
Journal:  Mol Hum Reprod       Date:  2009-08-19       Impact factor: 4.025

View more
  29 in total

1.  Fibrillin-containing microfibrils are key signal relay stations for cell function.

Authors:  Karina A Zeyer; Dieter P Reinhardt
Journal:  J Cell Commun Signal       Date:  2015-10-08       Impact factor: 5.782

2.  Copy number variation analysis in bicuspid aortic valve-related aortopathy identifies TBX20 as a contributing gene.

Authors:  Ilse Luyckx; Ajay A Kumar; Edwin Reyniers; Emily Dekeyser; Kathleen Vanderstraeten; Geert Vandeweyer; Florian Wünnemann; Christoph Preuss; Jean-Michaël Mazzella; Guillaume Goudot; Emmanuel Messas; Juliette Albuisson; Xavier Jeunemaitre; Per Eriksson; Salah A Mohamed; Marlies Kempers; Simone Salemink; Anthonie Duijnhouwer; Gregor Andelfinger; Harry C Dietz; Aline Verstraeten; Lut Van Laer; Bart L Loeys
Journal:  Eur J Hum Genet       Date:  2019-02-28       Impact factor: 4.246

Review 3.  Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood.

Authors:  David H Abbott; Fida Bacha
Journal:  Fertil Steril       Date:  2013-07       Impact factor: 7.329

4.  Limb- and tendon-specific Adamtsl2 deletion identifies a role for ADAMTSL2 in tendon growth in a mouse model for geleophysic dysplasia.

Authors:  Dirk Hubmacher; Nandaraj Taye; Zerina Balic; Stetson Thacker; Sheila M Adams; David E Birk; Ronen Schweitzer; Suneel S Apte
Journal:  Matrix Biol       Date:  2019-02-07       Impact factor: 11.583

5.  Human eye development is characterized by coordinated expression of fibrillin isoforms.

Authors:  Dirk Hubmacher; Dieter P Reinhardt; Thomas Plesec; Katja Schenke-Layland; Suneel S Apte
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-18       Impact factor: 4.799

Review 6.  Elastic Fibers and Large Artery Mechanics in Animal Models of Development and Disease.

Authors:  Maria Gabriela Espinosa; Marius Catalin Staiculescu; Jungsil Kim; Eric Marin; Jessica E Wagenseil
Journal:  J Biomech Eng       Date:  2018-02-01       Impact factor: 2.097

7.  Complex contributions of fibronectin to initiation and maturation of microfibrils.

Authors:  Laetitia Sabatier; Jelena Djokic; Christine Fagotto-Kaufmann; Marian Chen; Douglas S Annis; Deane F Mosher; Dieter P Reinhardt
Journal:  Biochem J       Date:  2013-12-01       Impact factor: 3.857

Review 8.  The role of TGF-β in polycystic ovary syndrome.

Authors:  Nazia Raja-Khan; Margrit Urbanek; Raymond J Rodgers; Richard S Legro
Journal:  Reprod Sci       Date:  2013-04-12       Impact factor: 3.060

9.  Evaluating reported candidate gene associations with polycystic ovary syndrome.

Authors:  Cindy Pau; Richa Saxena; Corrine Kolka Welt
Journal:  Fertil Steril       Date:  2013-01-30       Impact factor: 7.329

10.  Fibrillin-1 directly regulates osteoclast formation and function by a dual mechanism.

Authors:  Kerstin Tiedemann; Iris Boraschi-Diaz; Irina Rajakumar; Jasvir Kaur; Peter Roughley; Dieter P Reinhardt; Svetlana V Komarova
Journal:  J Cell Sci       Date:  2013-09-15       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.